Loading
BL
Britannia Life Sciences Inc. (formerly RISE Life Science Corp.) Stock: price and insider trades · Canada
Insider Decl.
10
Thresholds
n/a
Buy Volume
€303,537
2 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 5,251 of 26,380 companies
67.0
score / 100
Value58
Quality76
FCF yld-11%
Earn yld·
EV/EBITDA0.8x
ROE108%
Gross mgn21%
Net mgn·
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
CA$0.07
Analyst consensus
Income statement
RevenueCA$474.8k
Gross profitCA$101.7k21% margin
EBITDACA$13.7M2879% margin
Net incomeCA$14.7M4069.6% margin
Valuation
PER (trailing)0.6x
P/Book0.5x
Beta0.00
Balance sheet & cash
Market capCA$10.7M
Total debtCA$229.1k
Free Cash Flow-CA$1.2M
Debt / Equity1%
Profitability & ownership
ROE108.4%
ROA-5.2%
% insiders34.4%
% institutions0.7%
Last declaration on 1 December 2021
Declarations10 total
47,482 shares@ CA$0.161.6% of flowCommon SharesTSXSEDI:3839916
294,352 shares@ CA$0.169.7% of flowCommon SharesTSXSEDI:3839914
750,000 shares@ CA$0.2944.5% of flowCommon SharesTSXSEDI:3836139
Canonical exit: 16 Feb 2022 (T+90)
800,000 shares@ CA$0.2744.2% of flowCommon SharesTSXSEDI:3836138
Canonical exit: 16 Feb 2022 (T+90)
Common SharesTSXSEDI:3836140
Common SharesTSXSEDI:3835323
Common SharesTSXSEDI:3835325
Common SharesTSXSEDI:3833253
Common SharesTSXSEDI:3833237
Common SharesTSXSEDI:3833215
10 of 10 declarations
About Britannia Life Sciences Inc. (formerly RISE Life Science Corp.)
The 10 filings of Britannia Life Sciences Inc. (formerly RISE Life Science Corp.) fit into two weeks of November 2021. On November 18, 2021, Peter James Shippen, filed as 10% holder, director and senior officer, bought for EUR 152,294 then EUR 151,243, or EUR 303,537 in total: those are the only 2 purchases on file, and there is no sale. Shippen signs 7 of the 10 filings, including the 2 purchases. Three other senior officers lodge one filing each: Sarah Zilik, Boris Novansky and Mark Bowes-Cavanagh, the last also a 10% holder. Eight of the filings are of a kind other than purchase or sale. In all, 4 filers appear in the record. Transactions run from November 12 to November 26, 2021, and the filings were published between November 17 and December 1, 2021, a median of 6 days after the trade. The Canadian health care company, listed in Toronto, has a market capitalisation of CAD 10.7 million, with 34.4% held by insiders. No filing falls in the last twelve months.
